The Founders Building the Athlete-Longevity Industry

The athlete-longevity industry did not appear because athletes suddenly wanted to live longer. It appeared because a handful of founders built the tools that made performance and recovery measurable, then sold them first to elite teams and later to everyone else. The pattern repeats across the sector. Solve a hard problem for professionals, prove it on the most demanding users in the world, then scale down into the much larger consumer market of active adults who want to train and recover like the pros. Below are the companies and people driving that shift, and the investors betting on it. We have covered the hardware in detail in wearables in elite sport; this is about the businesses and the builders behind it.

Will Ahmed and WHOOP

WHOOP is the clearest example of the elite-to-consumer arc. Will Ahmed founded the company in 2012 while at Harvard, after becoming frustrated that athletes had no way to quantify how their bodies were actually recovering. WHOOP built a screenless wrist strap focused not on steps but on strain, recovery and sleep, sold as a membership rather than a one-time device.

The strategy was to win credibility at the top first. WHOOP became a fixture in professional locker rooms across the NBA, the NFL, golf and endurance sport before pushing into the mainstream fitness market. The company has raised substantial venture funding and reached a valuation in the billions of dollars at its peak, backed by investors including SoftBank. Ahmed’s central bet, that recovery is a measurable and trainable variable rather than a vague feeling, is the intellectual foundation of much of the sector. The science behind it connects directly to our coverage of sleep and athletic performance.

Catapult and the team-data layer

If WHOOP is the consumer face, Catapult is the professional backbone. The Australian company pioneered the GPS and accelerometer vests that elite teams wear in training, the small units between the shoulder blades that track distance, speed, acceleration and collision load. Catapult turned that data into the load-monitoring systems that now underpin injury prevention across football, rugby, Australian rules and dozens of other sports.

Catapult is publicly listed and works with thousands of teams worldwide, which makes it one of the more financially transparent players in a sector full of private valuations. Its importance is structural. The load-management revolution that extended careers in basketball and football, which we discuss in our piece on extending athletic careers, runs on exactly the kind of objective workload data Catapult was built to capture.

Hyperice and Normatec, recovery as a product

Recovery used to mean a physio’s table and a bag of ice. Hyperice turned it into consumer hardware. The company built percussive massage devices and, through its acquisition of Normatec, the pneumatic compression boots that became ubiquitous in professional training rooms and then in ordinary gyms. The founder, Anthony Katz, started from a personal injury problem and built it into a brand carried by leagues and endorsed by star athletes.

The honest caveat belongs here. The recovery-device category is commercially enormous but scientifically uneven, a tension we explore in recovery science. Percussive massage and compression have some supporting evidence for short-term soreness and perceived recovery, but the marketing often runs ahead of the data. Hyperice’s achievement is as much about brand and distribution as about clinical breakthrough, which is itself a lesson about how this industry actually grows.

Kitman Labs and the analytics bet

Less visible to consumers but increasingly central to teams is Kitman Labs, founded by Stephen Smith, a former rugby performance specialist. Kitman built a platform that integrates the flood of athlete data, training load, medical records, testing results, into a single system that helps teams predict and reduce injury risk. It is the integration layer, the software that tries to make sense of everything the wearables and vests produce.

This is the part of the market that arguably has the most room to grow, and the part most in need of operator-investors who understand data platforms rather than devices. The hard problem is no longer measuring the athlete. It is unifying the measurements into a decision, a point we made in our profile of Ankiti Bose and the business of sports longevity.

Oura and the crossover into sport

Oura began as a sleep and readiness ring aimed at the general wellness consumer, but it has steadily moved into sport, with team partnerships and a growing presence among athletes who want recovery and sleep tracking without a wrist device. Its arc runs in the opposite direction from Catapult, consumer first, then into elite sport, which makes it a useful case study in how porous the boundary between wellness and performance has become.

Oura has raised significant venture capital and reached a multibillion-dollar valuation, and its expansion into athletic use shows how the longevity and performance markets are converging. The same ring that tells a tech executive their sleep was poor tells a professional athlete the same thing, and the underlying biometrics are not that different.

Who is funding all of this

The capital behind the sector is a mix of mainstream venture firms, sovereign and strategic money, and sport-specific funds. SoftBank backed WHOOP. Large consumer and technology investors sit on the cap tables of Oura and Hyperice. A growing cluster of dedicated sports-tech and sports-medicine funds has emerged to back earlier-stage companies, and leagues and clubs themselves increasingly invest in or partner with the startups whose products they use.

The thesis tying it together is the same one driving the whole athlete-longevity economy. The tools that keep professionals performing longer are becoming consumer products for the far larger population of active adults who refuse to age quietly. The founders who win will be the ones who, like the best of those above, prove their product on the most demanding users first and then build the platform that scales it down to everyone else.

FAQ

Who founded WHOOP and what makes it different? Will Ahmed founded WHOOP in 2012. Its difference is the focus on strain, recovery and sleep rather than steps, sold as a membership, and its strategy of winning credibility among elite professional athletes before expanding to consumers. It helped popularize the idea that recovery is a measurable, trainable variable.

Do recovery devices like Hyperice and Normatec actually work? There is some evidence that percussive massage and pneumatic compression help with short-term soreness and perceived recovery, but the marketing frequently outpaces the science. They are useful tools rather than proven breakthroughs, and the category’s commercial success rests heavily on brand and distribution as well as on results.

What is the biggest opportunity in sports tech right now? The integration layer. Measuring athletes is largely solved by wearables and tracking vests; the unsolved problem is unifying all that data into reliable decisions about training, recovery and injury prevention. Companies like Kitman Labs work on exactly this, and it is the part of the market most in need of data-platform operators.

Sources

1. Will Ahmed and the rise of WHOOP, Forbes
2. Catapult Sports and athlete load monitoring, The Athletic
3. Hyperice, Normatec and the recovery-device market, CNBC
4. Kitman Labs and sports analytics, TechCrunch
5. Oura’s expansion into elite sport, Reuters
6. Evidence on recovery technology in sport, British Journal of Sports Medicine